RecruitingNCT05775484

Exercise to Slow Cardiovascular Ageing Progression

Sponsor

National Heart Centre Singapore

Enrollment

450 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Exercise Cardiovascular Cardiac Ageing

Summary

In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.

Eligibility

Min Age: 21 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cardiac ageing, cardiovascular, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.